Clinical Trial

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2023 (before its estimated March 17, 2024 completion). Its status may not reflect the trial's current state.
Summary
This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical treatments (experimental intervention) compared to standard drops of the same medication(s) (active comparator) in Wilford Hall Ambulatory Surgical Center (WHASC) primary open-angle glaucoma (POAG) and ocular hypertension (OHTN) patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-03.
Status change: Recruiting → Completed 2025-08-11
Trial Details
NCT Number NCT05844384
Lead Sponsor 59th Medical Wing
Collaborators: Nanodropper, Inc.
Conditions Ocular Hypertension, Primary Open Angle Glaucoma
Enrollment 30 participants
Start Date 2022-03-17
Primary Completion 2024-03-17 (estimated)
Study Completion 2024-03-17 (estimated)
Updated on ClinicalTrials.gov 2023-05-06